10.2 Evidence-Informed Decision Making & Authoritative Drug Information References

Evidence-Informed Decision Making & Authoritative Drug Information References

Exam Tip: In the OpenExamPrep independent study guide for the PEBC Pharmacy Technician Qualifying Examination, candidates are tested on their ability to locate reliable drug information swiftly and accurately. Candidates must know the specific strengths of Canadian references (CPS/RxTx, Health Canada DPD, LNHPD, provincial formularies) versus international specialty references (Trissel's, Briggs). Furthermore, exam questions consistently test the legal scope boundary: technicians independently retrieve and verify factual technical data, but must refer clinical evaluations and therapeutic recommendations to the pharmacist.

The Hierarchy of Drug Information Literature

Evidence-informed practice requires healthcare professionals to base technical and clinical decisions on current, high-quality biomedical evidence. Drug information literature is organized into a classical three-tiered hierarchy: primary, secondary, and tertiary resources.

                      ▲
                     / \
                    /   \
                   / Pri- \
                  /  mary  \
                 /----------\
                /  Secondary \
               /   Literature \
              /----------------\
             /     Tertiary     \
            /  Literature (CPS)  \
           /──────────────────────\

1. Primary Literature

• Definition: Original, unfiltered clinical research studies, randomized controlled trials (RCTs), observational cohort studies, case-control studies, and case reports published in peer-reviewed biomedical journals.
• Examples: Studies published in the Canadian Medical Association Journal (CMAJ), Canadian Journal of Hospital Pharmacy (CJHP), New England Journal of Medicine (NEJM), The Lancet, and Pharmacotherapy.
• Advantages: Provides the most up-to-date, granular data available; details experimental methodologies, statistical analyses, and emerging clinical endpoints.
• Disadvantages & Limitations: Requires advanced training in epidemiology and biostatistics to critically appraise; individual studies may have methodological flaws, small sample sizes, or commercial funding bias; synthesizing multiple conflicting studies is extremely time-consuming for frontline dispensary workflow.

2. Secondary Literature

• Definition: Indexing and abstracting bibliographic databases that organize, catalog, and locate primary literature.
• Examples:
  • PubMed / MEDLINE: Maintained by the US National Library of Medicine (NLM); uses MeSH (Medical Subject Headings) controlled vocabulary to index millions of biomedical articles.
  • Embase: Comprehensive European biomedical and pharmacological database with exceptional coverage of international drug trials and adverse drug reactions.
  • Cochrane Library: The premier international database of systematic reviews and meta-analyses, synthesizing high-quality RCTs to establish evidence-based clinical conclusions.
  • Google Scholar: Broad, multi-disciplinary search engine useful for quick keyword queries, but lacks controlled vocabulary and includes non-peer-reviewed preprints.
• Advantages: Enables targeted, rapid searches across vast bodies of published medical literature using Boolean operators (AND, OR, NOT) and publication filters.
• Disadvantages: Users must construct precise search queries; retrieving search results is merely the intermediary step—practitioners must still retrieve and appraise the underlying primary papers.

3. Tertiary Literature

• Definition: Condensed, evaluated, and synthesized information compiled by clinical experts from primary and secondary literature into accessible reference textbooks, monographs, online compendia, and clinical practice guidelines.
• Examples: Compendium of Pharmaceuticals and Specialties (CPS / RxTx), Lexicomp, Micromedex, Trissel's Handbook on Injectable Drugs, Briggs Drugs in Pregnancy and Lactation.
• Advantages: The first-line resource for everyday pharmacy practice. Information is evaluated, concise, user-friendly, and immediately applicable to frontline technical and clinical inquiries.
• Disadvantages: Publication lag time (information may be 1 to 2 years behind emerging primary trials); potential for interpretive bias or conflicting recommendations between different compendia.

Authoritative Canadian & International Drug Information Resources

In Canadian pharmacy practice, technicians must select the most authoritative, legally recognized, and clinically appropriate reference based on the specific nature of the inquiry.

1. Compendium of Pharmaceuticals and Specialties (CPS / RxTx)

Published by the Canadian Pharmacists Association (CPhA), the CPS is the most widely utilized and respected comprehensive drug compendium in Canada. Available in annual print editions and continually updated online/mobile formats (RxTx).

• Key Contents:
  • Manufacturer Product Monographs: Official Health Canada-approved prescribing information submitted by pharmaceutical manufacturers (identifying Canadian brand names, approved indications, dosage ranges, contraindications, adverse reactions, and storage conditions).
  • CPhA Monographs: Unbiased, evidence-based monographs authored by CPhA clinical editors for drugs with multiple generic manufacturers or where manufacturer monographs lack comprehensive comparative information.
  • Product Identification (Photo Index): Full-color, high-resolution photographs of tablets and capsules marketed in Canada, cross-referenced by color, shape, and markings—an indispensable tool for technicians identifying unknown loose medications.
  • Therapeutic Condition Overviews: Clinical reviews summarizing evidence-based treatment algorithms for common diseases.
  • Canadian Directory: Contact details for Canadian pharmaceutical manufacturers, poison control centers, and health organizations.

2. Health Canada Drug Product Database (DPD)

A publicly accessible, official regulatory database maintained directly by Health Canada.

• Key Contents:
  • Authoritative regulatory status for all human prescription drugs, over-the-counter pharmaceuticals, ethical products, and veterinary medicines approved for use in Canada.
  • Searchable by Drug Identification Number (DIN), active ingredient, brand name, manufacturer, anatomical therapeutic chemical (ATC) code, route of administration, and dosage form.
  • Market status verification: Identifies whether a product is currently Marketed, Cancelled Post-Market, Cancelled Pre-Market, or Dormant in Canada.
  • Direct access to official Health Canada-approved Product Monograph (PM) PDFs, including recent safety revisions and black-box warnings.

3. Licensed Natural Health Products Database (LNHPD)

Operated by Health Canada to support the Natural and Non-prescription Health Products Directorate (NNHPD).

• Key Contents:
  • Contains all natural health products (NHPs) licensed for sale in Canada holding an 8-digit Natural Product Number (NPN) or Homeopathic Medicine Number (DIN-HM).
  • Outlines approved medicinal ingredients, source materials, strengths, authorized health claims, recommended daily dosages, and mandatory risk statements (cautions, contraindications, and potential adverse effects).

4. Provincial Drug Benefit Formularies

Each Canadian province and territory publishes its own statutory drug benefit formulary (e.g., Ontario Drug Benefit [ODB] Formulary / e-Formulary, Alberta Health Care Insurance Plan Drug Benefit List [DBL], British Columbia PharmaCare Formulary, RAMQ in Quebec).

• Key Contents:
  • Identifies which medications are covered under provincial public health plans for seniors, social assistance recipients, and specialized disease programs.
  • Designates Interchangeable Products: Authoritative provincial legal groupings of bioequivalent generic medications that community pharmacies may substitute without contacting the prescriber.
  • Outlines coverage mechanisms: General benefit, Limited Use (LU) with specific clinical criteria codes, and Exceptional Access Programs (EAP) / Special Authorization requiring prescriber application.
  • Establishes maximum allowable reimbursement costs and provincial copayment/deductible rules.

5. Specialized Tertiary References

When an inquiry moves beyond standard dosing or general monograph information, technicians must access specialized tertiary reference texts:

Evaluating Online Health Information Credibility

Patients and healthcare personnel frequently turn to the internet for health information. In accordance with NAPRA competencies, pharmacy technicians must critically appraise online sources to steer patients away from harmful misinformation.

Source Evaluation Criteria

When reviewing online health content, technicians apply credibility criteria like those used by the former Health On the Net (HONcode) certification (discontinued in 2022):

1. Authority & Credentials: Is the author a recognized, licensed healthcare professional or accredited medical institution? Are author affiliations clearly disclosed?
2. Attribution & Evidence (Citations): Does the content cite peer-reviewed primary clinical trials, consensus guidelines, or authoritative government bodies? Are direct links or references provided?
3. Currency & Timeliness: Is there a visible "Last Updated" or revision date? Clinical data older than 3 to 5 years without subsequent review may be obsolete.
4. Commercial Bias & Transparency: Is the website sponsored by a pharmaceutical company or commercial entity attempting to sell a proprietary supplement or device? Commercial conflicts of interest must be explicitly declared.
5. Objectivity vs. Testimonials: Does the site rely on dramatic individual anecdotes, miraculous "cure-all" claims, or emotionally charged language rather than scientific trial data? Extraordinary claims lacking reproducible evidence are classic red flags for healthcare fraud.

Scope Boundaries: Technician Retrieval vs. Pharmacist Clinical Consultation

A central focus of Canadian pharmacy regulation (NAPRA Professional Competencies for Pharmacy Technicians) is the precise distinction between technical drug information retrieval and clinical pharmacotherapy evaluation.

Pharmacy Technician Scope (Technical Data Retrieval)

Technicians are fully authorized and expected to independently search, locate, retrieve, verify, and document factual, standardized drug data, including:

• Locating official Drug Identification Numbers (DINs) and Natural Product Numbers (NPNs).
• Retrieving manufacturer reconstitution instructions, required diluent volumes, and beyond-use dates (BUDs) from product monographs.
• Verifying proper storage temperatures (refrigerated 2°C to 8°C, room temperature 15°C to 30°C, protected from light, do not freeze).
• Checking available commercial dosage forms, package sizes, strengths, and manufacturer backorder/discontinuation notices.
• Identifying bioequivalent interchangeable generic products listed on provincial formularies.
• Looking up straightforward IV Y-site compatibility tables in Trissel's Handbook for standard parenteral admixtures.

Pharmacist Scope (Clinical Evaluation & Recommendation)

Any inquiry that requires professional judgment to interpret clinical implications, balance risks versus benefits, or tailor pharmacotherapy to an individual patient's unique physiological profile must be referred immediately to a licensed pharmacist, including:

• Evaluating the clinical significance of a drug-drug, drug-disease, or drug-nutrient interaction.
• Calculating renal dose adjustments for patients with reduced creatinine clearance (eGFR).
• Recommending therapeutic alternatives during drug shortages or formulary exclusions.
• Assessing the clinical safety of a medication during pregnancy or breastfeeding.
• Counseling patients regarding therapeutic expectations, potential adverse drug reactions, or missed-dose strategies.
• Evaluating the therapeutic appropriateness of off-label medication orders.